Mapping the Vif-A3G interaction using peptide arrays: A basis for anti-HIV lead peptides

Keyphrases

• N-terminal Domain 100%
• Peptide Array 100%
• Anti-HIV 100%
• Anti-HIV-1 100%
• Enzymatic Activity 50%
• Binding Site 50%
• Interaction Sites 50%
• Polypeptide 50%
• Binding Peptide 50%
• Human Immunodeficiency Virus Type 1 (HIV-1) 50%
• Cell Culture 50%
• Direct Interaction 50%
• Cellular Immunity 50%
• RNA Editing 50%
• Binding Region 50%
• Retrovirus 50%
• Antiviral Activity 50%
• Complex Interactions 50%
• Direct Inhibitors 50%
• Cytidine Deaminase 50%
• Apolipoprotein B (Apo B) 50%
• HIV-1 Replication 50%
• HIV-1 Vif 50%
• DNA Virus 50%
• Stronger Binding 50%
• Endogenous Retroelements 50%
• In Vivo Co-localization 50%

Biochemistry, Genetics and Molecular Biology

• Human Immunodeficiency Virus 1 100%
• Human Immunodeficiency Virus 100%
• C-Terminus 60%
• N-Terminus 40%
• Enzyme Activity 20%
• Binding Site 20%
• Cell Culture 20%
• Fluorescence Resonance Energy Transfer 20%
• Cellular Immunity 20%
• Apolipoprotein B 20%
• Cytidine Deaminase 20%
• Endogenous Retrovirus 20%
• Retroelement 20%
• Antiviral Activity 20%
• Messenger RNA 20%
• DNA Virus 20%

Immunology and Microbiology

• Human Immunodeficiency Virus 100%
• Peptides 100%
• Human Immunodeficiency Virus 1 71%
• Carboxy Terminal Sequence 42%
• Amino Terminal Sequence 28%
• Binding Site 14%
• Adoptive Immunity 14%
• Enzyme Activity 14%
• Cell Culture 14%
• Endogenous Retrovirus 14%
• Antiviral Activity 14%
• DNA Virus 14%
• Apolipoprotein B 14%
• Replication 14%